Metis Global Partners, LLC Viatris Inc Transaction History
Metis Global Partners, LLC
- $2.87 Billion
- Q2 2024
A detailed history of Metis Global Partners, LLC transactions in Viatris Inc stock. As of the latest transaction made, Metis Global Partners, LLC holds 37,520 shares of VTRS stock, worth $430,354. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,520
Previous 38,284
2.0%
Holding current value
$430,354
Previous $457,000
12.91%
% of portfolio
0.01%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding VTRS
# of Institutions
1,099Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.61 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.06 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$712 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$660 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$652 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...